CN113730552A - Composition for improving physiological functions of livestock and poultry and preparation method thereof - Google Patents
Composition for improving physiological functions of livestock and poultry and preparation method thereof Download PDFInfo
- Publication number
- CN113730552A CN113730552A CN202111096924.2A CN202111096924A CN113730552A CN 113730552 A CN113730552 A CN 113730552A CN 202111096924 A CN202111096924 A CN 202111096924A CN 113730552 A CN113730552 A CN 113730552A
- Authority
- CN
- China
- Prior art keywords
- composition
- parts
- livestock
- improving
- transfer factor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 102
- 244000144972 livestock Species 0.000 title claims abstract description 44
- 230000035790 physiological processes and functions Effects 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 244000144977 poultry Species 0.000 title claims description 34
- 108010074506 Transfer Factor Proteins 0.000 claims abstract description 37
- 210000002826 placenta Anatomy 0.000 claims abstract description 21
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims abstract description 20
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 13
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229920002643 polyglutamic acid Polymers 0.000 claims abstract description 13
- 239000011669 selenium Substances 0.000 claims abstract description 13
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 13
- 241001494479 Pecora Species 0.000 claims abstract description 12
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims abstract description 12
- 229960004494 calcium gluconate Drugs 0.000 claims abstract description 12
- 239000004227 calcium gluconate Substances 0.000 claims abstract description 12
- 235000013927 calcium gluconate Nutrition 0.000 claims abstract description 12
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims abstract description 12
- 239000011670 zinc gluconate Substances 0.000 claims abstract description 12
- 235000011478 zinc gluconate Nutrition 0.000 claims abstract description 12
- 229960000306 zinc gluconate Drugs 0.000 claims abstract description 12
- 235000010355 mannitol Nutrition 0.000 claims abstract description 10
- 229940088594 vitamin Drugs 0.000 claims abstract description 8
- 229930003231 vitamin Natural products 0.000 claims abstract description 8
- 235000013343 vitamin Nutrition 0.000 claims abstract description 8
- 239000011782 vitamin Substances 0.000 claims abstract description 8
- 239000004480 active ingredient Substances 0.000 claims abstract description 3
- 239000000843 powder Substances 0.000 claims description 47
- 238000000034 method Methods 0.000 claims description 13
- 238000002156 mixing Methods 0.000 claims description 12
- 239000002002 slurry Substances 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 12
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 10
- 241000283898 Ovis Species 0.000 claims description 7
- 238000000465 moulding Methods 0.000 claims description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 229930003316 Vitamin D Natural products 0.000 claims description 5
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 5
- 229930003427 Vitamin E Natural products 0.000 claims description 5
- 238000004108 freeze drying Methods 0.000 claims description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 239000002504 physiological saline solution Substances 0.000 claims description 5
- 235000019166 vitamin D Nutrition 0.000 claims description 5
- 239000011710 vitamin D Substances 0.000 claims description 5
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 5
- 235000019165 vitamin E Nutrition 0.000 claims description 5
- 229940046009 vitamin E Drugs 0.000 claims description 5
- 239000011709 vitamin E Substances 0.000 claims description 5
- 229940045997 vitamin a Drugs 0.000 claims description 5
- 229940046008 vitamin d Drugs 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 4
- 238000007710 freezing Methods 0.000 claims description 4
- 230000008014 freezing Effects 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 4
- 238000005360 mashing Methods 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 238000010257 thawing Methods 0.000 claims description 4
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 3
- 235000013336 milk Nutrition 0.000 abstract description 15
- 239000008267 milk Substances 0.000 abstract description 15
- 210000004080 milk Anatomy 0.000 abstract description 15
- 241001465754 Metazoa Species 0.000 abstract description 14
- 238000009395 breeding Methods 0.000 abstract description 11
- 230000001488 breeding effect Effects 0.000 abstract description 11
- 229960005486 vaccine Drugs 0.000 abstract description 10
- 241000271566 Aves Species 0.000 abstract description 9
- 241000283690 Bos taurus Species 0.000 abstract description 9
- 235000013365 dairy product Nutrition 0.000 abstract description 7
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- 208000002979 Influenza in Birds Diseases 0.000 abstract description 6
- 208000010359 Newcastle Disease Diseases 0.000 abstract description 6
- 206010064097 avian influenza Diseases 0.000 abstract description 6
- 230000028993 immune response Effects 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 5
- 230000002195 synergetic effect Effects 0.000 abstract description 5
- 239000003651 drinking water Substances 0.000 abstract description 4
- 235000020188 drinking water Nutrition 0.000 abstract description 4
- 230000017448 oviposition Effects 0.000 abstract description 4
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 abstract description 3
- 239000003674 animal food additive Substances 0.000 abstract description 3
- -1 compound vitamin Chemical class 0.000 abstract description 3
- 241000272496 Galliformes Species 0.000 abstract description 2
- 230000000840 anti-viral effect Effects 0.000 abstract description 2
- 238000006243 chemical reaction Methods 0.000 abstract description 2
- 238000013329 compounding Methods 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 description 33
- 235000013594 poultry meat Nutrition 0.000 description 22
- 230000001965 increasing effect Effects 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 12
- 241000287828 Gallus gallus Species 0.000 description 10
- 238000011161 development Methods 0.000 description 8
- 230000004083 survival effect Effects 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- 238000010998 test method Methods 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 238000012544 monitoring process Methods 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000013601 eggs Nutrition 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000035931 haemagglutination Effects 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000001726 Classical Swine Fever Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229960005004 cholera vaccine Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/24—Compounds of alkaline earth metals, e.g. magnesium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/10—Shaping or working-up of animal feeding-stuffs by agglomeration; by granulation, e.g. making powders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/315—Zinc compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Reproductive Health (AREA)
- Physiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to the technical field of livestock breeding, in particular to a composition for improving the physiological function of livestock and a preparation method thereof. The composition is prepared by compounding sheep placenta transfer factor, compound vitamin, selenium yeast, calcium gluconate, zinc gluconate, gamma-polyglutamic acid and D-mannitol serving as active ingredients according to a certain mass ratio, can be used as a feed additive, and is added into drinking water or directly injected for use. The components have synergistic effect, so that the growth performance of young birds and young animals is improved, the death rate of the young birds and the young animals is reduced, the growth rate is improved, the immunity of the organism is improved, the immune response reaction of the organism to common vaccines such as newcastle disease, avian influenza and the like is improved, the capacity of the organism to generate effective antibodies after the vaccine is injected into the organism is improved, and the antiviral capacity of the organism is improved; meanwhile, the composition can also effectively improve the production performance of laying fowls in the egg laying period, the milk yield of dairy cows, the milk production period and the like.
Description
Technical Field
The invention relates to the technical field of livestock breeding, in particular to a composition for improving the physiological function of livestock and a preparation method thereof.
Background
Livestock and poultry breeding occupies an important proportion in agricultural economy in China and is a dominant industry in traditional agriculture in China. Livestock and poultry breeding is an economic source of farmers and is related to the healthy development of the society in China. The livestock and poultry breeding industry in China is gradually developing towards scale and standardization. Under the traditional industrialized breeding mode, livestock and poultry receive the invasion of various pathogenic microorganisms, the organism immunity of the livestock and poultry can resist the invasion of the pathogenic microorganisms under the normal condition, the possibility that pathogens invade the organism of the livestock and poultry is increased along with the reduction of the immunity, and meanwhile, the immune system can not generate normal immune response, so that the morbidity of the livestock and poultry is increased, and serious economic loss is generated.
Therefore, people realize that the production performances of reducing the casualty rate of young birds and young livestock, improving the physiological functions of the young birds and the young livestock, reducing the risks of diseases, improving the growth and development rate, improving the egg laying period of laying birds, the milk yield of dairy cows, the milk producing period and the like are important directions for increasing the income in the breeding process. A plurality of vaccine products or feed additive products exist in the market, and are used for reducing the infection of viruses or bacteria, improving the physiological function of livestock and poultry, increasing the growth and development rate and increasing the egg and milk yield. However, with the development of economy and the improvement of the living standard of people, people particularly favor green, safe and pollution-free pure natural food, and especially have stricter requirements on the quality of meat, eggs and dairy products. In order to simultaneously meet the improvement of economic benefits of livestock and poultry breeding and ensure the quality of green, healthy, pollution-free and drug residue-free meat, eggs and dairy products, people begin to develop products which can be repeatedly added and used in the whole growth cycle of livestock and poultry breeding and can improve the comprehensive physiological functions of livestock and poultry, thereby achieving the purposes of safety, greenness, decomposition and no drug resistance and drug residue.
The transfer factor is a substance which is released by lymphocytes and can transfer sensitization information, does not contain protein, is small molecular polypeptide, contains more than 6 amino acids, has molecular weights of different animals and different antigen-specific transfer factors, and has certain difference between a large number of peptide molecules and the types of the amino acids. The transfer factor has no heat source, the activity of the transfer factor is not destroyed by pancreatin, but the transfer factor is unstable to heat, and the transfer factor can specifically transfer the cellular immune information of a donor to a receptor, thereby enhancing the immune function of the receptor. In addition to being widely applied to human medicine, transfer factors are also widely used in products such as additives for enhancing immunity of livestock and poultry in recent years. How to select a transfer factor with a proper source according to a specific product function requirement, how to improve the effective utilization rate of an organism to the transfer factor and improve the comprehensive performance of a product becomes a technical problem to be solved urgently at present.
Disclosure of Invention
In order to overcome the defects of the prior art, the invention aims to provide the composition for improving the physiological function of the livestock and poultry, the transfer factor is compounded with compound vitamin, multiple trace elements, polyglutamic acid and the like, and the growth performance of young birds and young animals, the production performance of laying birds, the milk yield of dairy cows, the milk producing period and the like are improved.
Meanwhile, the invention also provides a preparation method of the composition for improving the physiological function of the livestock and poultry.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows:
a composition for improving the physiological functions of livestock and poultry is prepared from the following effective components in parts by mass: 35-45 parts of sheep placenta transfer factor, 6-12 parts of vitamin complex, 0.8-1.2 parts of yeast selenium, 8-12 parts of calcium gluconate, 8-12 parts of zinc gluconate, 15-25 parts of gamma-polyglutamic acid and 8-12 parts of D-mannitol.
Further preferably, the composition for improving the physiological functions of the livestock and poultry is prepared from the following effective components in parts by mass: 40 parts of placenta caprae seu ovis transfer factor, 9 parts of vitamin complex, 1 part of selenium yeast, 10 parts of calcium gluconate, 10 parts of zinc gluconate, 20 parts of gamma-polyglutamic acid and 10 parts of D-mannitol.
Preferably, in a particular embodiment of the invention, the multivitamins are formed from vitamin a, vitamin D and vitamin E in a ratio of 1: 1: 1, and the components are compounded according to the mass ratio.
Optionally, the composition is freeze-dried powder, and the composition can be microcapsule granules or other formulations according to the requirements of practical application scenes.
The preparation method of the composition for improving the physiological functions of the livestock and the poultry comprises the following operation steps:
1) size mixing: taking the effective components according to the mass part, adding sterile normal saline, and uniformly mixing to obtain composition slurry;
2) molding: is prepared by molding according to the dosage form of the composition.
Preferably, in the step 1), the ratio of the materials to the liquid is 1: adding physiological saline in a ratio of 0.8-1.2.
Optionally, the preparation of the sheep placenta transfer factor before the plasma mixing comprises the steps of taking fresh sheep placenta to remove fat and envelope, mashing, grinding, crushing by ultrasonic cells, repeatedly freezing and thawing after crushing the cells, centrifuging to take supernatant, filtering, performing molecular interception to obtain a transfer factor solution of less than 1000 daltons, measuring the concentration of the transfer factor contained in the transfer factor solution, and taking the transfer factor solution according to the mass parts of the sheep placenta transfer factor in the composition. Preferably, the cells are disrupted and then freeze-thawed 3 times repeatedly.
Preferably, after the physiological saline is added in the step 1), the mixture is uniformly mixed at the temperature of 2-8 ℃, and the pH = 6.5-7.5 is adjusted to obtain the composition slurry.
Preferably, the step 2) of forming comprises the step of freeze-drying the composition slurry prepared in the step 1) to prepare the composition freeze-dried powder for improving the physiological function of the livestock.
The composition for improving the physiological functions of the livestock and poultry is prepared by compounding sheep placenta transfer factor, compound vitamin, selenium yeast, calcium gluconate, zinc gluconate, gamma-polyglutamic acid and D-mannitol which serve as active ingredients according to a certain mass ratio, and can be used as a feed additive, or added into drinking water, or used by injection. The components have synergistic effect, so that the growth performance of young birds and young animals is improved, the death rate of the young birds and the young animals is reduced, the growth rate is improved, the immunity of the organism is improved, the immune response reaction of the organism to common vaccines such as newcastle disease, avian influenza and the like is improved, the capacity of the organism to generate effective antibodies after the vaccine is injected into the organism is improved, and the antiviral capacity of the organism is improved; meanwhile, the composition can also effectively improve the production performance of laying fowls in the egg laying period, the milk yield of dairy cows, the milk production period and the like.
The preparation method of the composition is simple and convenient to operate, easy to control and suitable for industrial production.
Detailed Description
The technical solution of the present invention will be described in detail by specific examples.
The placenta transfer factor used in the following examples and comparative examples was prepared by the following method:
removing fat and envelope from fresh placenta caprae seu ovis, mashing, grinding, ultrasonic cell disruption, repeatedly freezing and thawing for 3 times after cell disruption, centrifuging to obtain supernatant, filtering, performing molecular interception to obtain transfer factor solution below 1000 daltons, and determining the concentration of transfer factor contained therein.
Vitamins, selenium yeast, calcium gluconate, zinc gluconate, gamma-polyglutamic acid, D-mannitol used in the following examples and comparative examples are all commercially available products; wherein the gamma-polyglutamic acid is prepared by fermenting bacillus subtilis.
Example 1
A composition for improving the physiological functions of livestock and poultry is prepared from the following effective components in parts by mass: 40 parts of placenta caprae seu ovis transfer factor, 3 parts of vitamin A, 3 parts of vitamin D, 3 parts of vitamin E, 1 part of yeast selenium, 10 parts of calcium gluconate, 10 parts of zinc gluconate, 20 parts of gamma-polyglutamic acid and 10 parts of D-mannitol.
The preparation method of the composition of this example comprises the following specific steps:
1) size mixing: taking the effective component components according to the mass portion, wherein the material-liquid ratio is 1: 1, supplementing sterile normal saline, uniformly mixing at the temperature of 2-8 ℃, and adjusting the pH =7.0 to obtain composition slurry;
2) molding: freeze-drying the composition slurry prepared in the step 1) to prepare the composition freeze-dried powder for improving the physiological function of the livestock.
Example 2
A composition for improving the physiological functions of livestock and poultry is prepared from the following effective components in parts by mass: 35 parts of placenta caprae seu ovis transfer factor, 4 parts of vitamin A, 4 parts of vitamin D, 4 parts of vitamin E, 1.2 parts of yeast selenium, 8 parts of calcium gluconate, 12 parts of zinc gluconate, 15 parts of gamma-polyglutamic acid and 8 parts of D-mannitol.
The preparation method of the composition of this example comprises the following specific steps:
1) size mixing: taking the effective component components according to the mass portion, wherein the material-liquid ratio is 1: 0.8 adding sterile normal saline, uniformly mixing at 28 ℃, and adjusting the pH =6.5 to obtain composition slurry;
2) molding: freeze-drying the composition slurry prepared in the step 1) to prepare the composition freeze-dried powder for improving the physiological function of the livestock.
Example 3
A composition for improving the physiological functions of livestock and poultry is prepared from the following effective components in parts by mass: 45 parts of placenta caprae seu ovis transfer factor, 2 parts of vitamin A, 2 parts of vitamin D, 2 parts of vitamin E, 0.8 part of yeast selenium, 12 parts of calcium gluconate, 8 parts of zinc gluconate, 25 parts of gamma-polyglutamic acid and 12 parts of D-mannitol.
The preparation method of the composition of this example comprises the following specific steps:
1) size mixing: taking the effective component components according to the mass portion, wherein the material-liquid ratio is 1: 1.2 supplementing sterile normal saline, uniformly mixing at the temperature of 2-8 ℃, and adjusting the pH =7.5 to obtain composition slurry;
2) molding: freeze-drying the composition slurry prepared in the step 1) to prepare the composition freeze-dried powder for improving the physiological function of the livestock.
Comparative example 1
The composition provided in this comparative example is different from example 1 in that gamma-polyglutamic acid is omitted and the amount of placenta transfer factor is increased by 60 parts, and the other steps are the same as example 1.
Comparative example 2
The composition provided by the comparative example is different from the composition provided by the example 1 in that the selenium yeast is saved, the dosage of the sheep placenta transfer factor is increased to 50 parts, and the rest is the same as the composition provided by the example 1.
Comparative example 3
The composition provided by the comparative example is different from that of example 1 in that the amounts of the yeast selenium, the zinc gluconate and the calcium gluconate are adjusted to 11 parts of the yeast selenium, 5 parts of the zinc gluconate and 5 parts of the calcium gluconate, and the rest is the same as that of example 1.
Test example 1
(1) Freeze-dried powder of the test composition:
composition freeze-dried powder prepared in example 1 and comparative examples 1-3
(2) Test animals and groups
6000 broiler chickens just hatched are randomly and averagely divided into five groups, each group comprises 1200 broiler chickens, and each group comprises A, B, C, D, E groups, wherein group A corresponds to composition freeze-dried powder of example 1, group B corresponds to composition freeze-dried powder of proportion 1, group C corresponds to composition freeze-dried powder of proportion 2, group D corresponds to composition freeze-dried powder of proportion 3, and group E corresponds to blank control group
(3) Test method
(3.1) test site: jincheng Jinyuan agriculture and animal husbandry development limited company cooperative pasture
(3.2) feeding method: normally breeding each group of tested broilers, immunizing newcastle disease and avian influenza, feeding corresponding composition freeze-dried powder for two times every day by concentrated drinking water on the 7 th day, the 21 st day and the 28 th day respectively, wherein the blank control group is fed with the same amount of physiological saline, and the feeding amount of the composition freeze-dried powder is 0.5 mg/kg;
(3.3) data statistics:
randomly weighing the initial average weight of 100 tested broilers in each group, marking, weighing the same 100 average weights after feeding for 30 days (if death occurs, randomly supplementing the tested broilers with the same weight as a supplementary sample), and calculating the average daily gain;
counting the survival rate = survival number/original number of each group of tested broilers after feeding for 40 days;
after feeding the tested broilers for 7 days, 21 days and 28 days, immunizing newcastle disease and avian influenza H7N9 vaccines respectively, randomly extracting blood samples of 100 surviving tested broilers, and after feeding the tested broilers for 30 days, performing newcastle disease antibody titer detection on the collected blood samples by adopting an ELISA method; monitoring the level of avian influenza H7N9 antibody in blood by indirect hemagglutination; (3.4) test results:
the statistical results of the body weight and survival rate data of each test group are shown in the following table 1:
TABLE 1
The number of the tested broilers corresponding to different antibody titers of newcastle disease in each test group is shown in the following table 2:
TABLE 2
The results of monitoring the avian influenza H7N9 antibody titers for each test group are shown in table 3 below:
TABLE 3
It is to be noted that the composition freeze-dried powder provided in examples 2 and 3 of the present invention was verified to have substantially the same improvement in physiological function of chicks as in example 1 according to the same test method as described above.
And (4) conclusion: the data described in tables 1 and 2 indicate that the effective components in the composition freeze-dried powder provided by the invention exert synergistic effect, so that the growth rate of the chicks is increased, the survival rate is increased, and the immune response effect to vaccines and the like is improved.
Test example 2
(1) Test composition freeze-dried powder:
composition freeze-dried powder prepared in example 1 and comparative examples 1-3
(2) Test animals and groups
400 piglets at the beginning of birth are randomly and averagely divided into five groups, wherein 80 piglets in each group are respectively A1, B1, C1, D1 and E1 groups, wherein A1 group corresponds to the composition freeze-dried powder in the example 1, B1 group corresponds to the composition freeze-dried powder in the proportion 1, C1 group corresponds to the composition freeze-dried powder in the proportion 2, D1 group corresponds to the composition freeze-dried powder in the proportion 3, and E1 group is a blank control group
(3) Test method
(3.1) test site: jincheng Jinyuan agriculture and animal husbandry development limited company cooperative pasture
(3.2) feeding method: normally breeding each group of tested piglets, injecting classical swine fever vaccine for epidemic prevention at the age of 25-30 days, injecting corresponding composition freeze-dried powder into each test group at the 1 st day, the 10 th day, weaning and turning, wherein the blank control group is injected with physiological saline with the same amount, and the injection dosage of the composition freeze-dried powder is 0.5 mg/kg;
(3.3) data statistics:
weighing the initial average weight of each tested piglet and the average weight after feeding for 50 days, and calculating the average daily gain;
counting survival = survival/primary number for each group of tested piglets;
respectively injecting the hog cholera vaccine for 15 days and 30 days, randomly selecting 20 tested piglets in each group, and monitoring the antibody level in blood by adopting an indirect hemagglutination method;
(3.4) test results:
the statistical results of the body weight and survival rate data for each test group are shown in table 4 below:
TABLE 4
The results of monitoring antibody levels 15 days after injection of swine fever vaccine are shown in table 5 below, and the results of monitoring antibody levels 30 days are shown in table 6 below: wherein the qualification rate of the antibody titer is the number/total number of piglets with the antibody titer achieving the effective protection effect
TABLE 5
TABLE 6
It should be noted that, according to the same test method as described above, it is verified that the composition freeze-dried powder provided in examples 2 and 3 of the present invention has substantially the same improvement on the physiological function of piglets as in example 1.
And (4) conclusion: the data recorded in tables 3, 4 and 5 indicate that the effective components in the composition freeze-dried powder provided by the invention exert synergistic effect, so that the growth rate of piglets is increased, the survival rate is increased, and the immune response effect to vaccines and the like is improved.
Test example 3
(1) Freeze-dried powder of the test composition:
composition freeze-dried powder prepared in example 1 and comparative examples 1-3
(2) Test animals and groups
500 laying hens entering an egg producing period are randomly divided into five groups of A2, B2, C2, D2 and E2, and each group comprises 100 laying hens, wherein the group A2 corresponds to the composition freeze-dried powder in the embodiment 1, the group B2 corresponds to the composition freeze-dried powder in the proportion 1, the group C2 corresponds to the composition freeze-dried powder in the proportion 2, the group D2 corresponds to the composition freeze-dried powder in the proportion 3, and the group E2 is a blank control group
(3) Test method
(3.1) test site: jincheng Jinyuan agriculture and animal husbandry development limited company cooperative pasture
(3.2) test process and statistical result:
feeding the tested laying hens of each test group with the corresponding composition freeze-dried powder by drinking water every 10 days, wherein the dosage of the composition freeze-dried powder is 0.5mg/kg, and counting the time for improving the laying period of each composition freeze-dried powder test group averagely compared with a control group, wherein the result is 25 days for A2 group; group B2 for 10 days; c2 group 10 days; d2 group 5 days.
Test example 4
(1) Freeze-dried powder of the test composition:
composition freeze-dried powder prepared in example 1 and comparative examples 1-3
(2) Test animals and groups
Selecting 500 cows, randomly dividing into five groups of A3, B3, C3, D3 and E3, and 100 cows in each group, wherein A3 group corresponds to the freeze-dried powder of the composition in example 1, B3 group corresponds to the freeze-dried powder of the composition in proportion 1, C3 group corresponds to the freeze-dried powder of the composition in proportion 2, D3 group corresponds to the freeze-dried powder of the composition in proportion 3, and E3 group is a blank control group
3. Test method
3.1 test field: jincheng Jinyuan agriculture and animal husbandry development limited company cooperative pasture
3.2 test process and statistical results:
the tested dairy cows of each test group are injected with the corresponding composition freeze-dried powder every 10 days, the dosage of the composition freeze-dried powder is 0.5mg/kg, compared with the control group, statistics shows that the milk yield of each composition freeze-dried powder test group is averagely improved, and the result is 7 percent of that of the A3 group; b3 group 5%; c3 group 4%; d3 group 2%;
counting the time for averagely increasing the milk production peak period of each composition freeze-dried powder test group compared with a control group, wherein the result is 15 days for A3 group; group B3 for 12 days; c3 group 10 days; d3 group 5 days.
The test results of the test example 3 and the test example 4 show that the effective components in the composition freeze-dried powder provided by the invention exert a synergistic effect, the egg laying period of the laying fowl and the milk producing period of the milk cow are prolonged, and the milk producing amount of the milk cow is increased.
Finally, it should be noted that: the above examples are only intended to illustrate the technical solution of the present invention, but not to limit it; although the present invention has been described in detail with reference to the foregoing embodiments, it will be understood by those of ordinary skill in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some technical features may be equivalently replaced; and such modifications or substitutions do not depart from the spirit and scope of the corresponding technical solutions of the embodiments of the present invention.
Claims (10)
1. The composition for improving the physiological functions of livestock and poultry is characterized by being prepared from the following effective components in parts by mass: 35-45 parts of sheep placenta transfer factor, 6-12 parts of vitamin complex, 0.8-1.2 parts of yeast selenium, 8-12 parts of calcium gluconate, 8-12 parts of zinc gluconate, 15-25 parts of gamma-polyglutamic acid and 8-12 parts of D-mannitol.
2. The composition for improving the physiological functions of livestock and poultry according to claim 1, which is prepared from the following active ingredients in parts by mass: 40 parts of placenta caprae seu ovis transfer factor, 9 parts of vitamin complex, 1 part of selenium yeast, 10 parts of calcium gluconate, 10 parts of zinc gluconate, 20 parts of gamma-polyglutamic acid and 10 parts of D-mannitol.
3. The composition for improving the physiological functions of livestock and poultry according to claim 1 or 2, wherein the sheep placenta transfer factor is prepared by the following method: removing fat and envelope from fresh placenta caprae seu ovis, mashing, grinding, ultrasonic cell disruption, repeatedly freezing and thawing after cell disruption, centrifuging to obtain supernatant, filtering, and molecular interception to obtain transfer factor solution below 1000 daltons.
4. The composition for improving the physiological functions of livestock and poultry according to claim 1 or 2, wherein said multivitamins are prepared from vitamin a, vitamin D and vitamin E in a ratio of 1: 1: 1, and the components are compounded according to the mass ratio.
5. The composition for improving the physiological functions of livestock and poultry according to claim 1 or 2, wherein the dosage form of the composition is freeze-dried powder.
6. The preparation method of the composition for improving the physiological functions of livestock and poultry according to any one of claims 1 to 5, which is characterized by comprising the following operation steps:
1) size mixing: taking the effective components according to the mass part, adding sterile normal saline, and uniformly mixing to obtain composition slurry;
2) molding: is prepared by molding according to the dosage form of the composition.
7. The method for preparing the composition for improving the physiological functions of livestock and poultry according to claim 6, wherein the ratio of the feed to the liquid in the step 1) is 1: sterile normal saline is added in the proportion of 0.8-1.2.
8. The method for preparing the composition for improving the physiological functions of livestock and poultry according to claim 6, wherein the preparation of the sheep placenta transfer factor before the plasma mixing comprises the steps of taking fresh sheep placenta to remove fat and envelope, mashing and grinding, crushing ultrasonic cells, repeatedly freezing and thawing for 3 times after crushing the cells, centrifuging to take supernatant, filtering, performing molecular interception to obtain a transfer factor solution with the concentration of the transfer factor below 1000 daltons, measuring the concentration of the transfer factor contained in the transfer factor solution, and taking the transfer factor solution according to the mass parts of the sheep placenta transfer factor in the composition.
9. The method for preparing the composition for improving the physiological functions of livestock and poultry according to claim 6, wherein the sterile physiological saline is added in the step 1), and then the mixture is uniformly mixed at the temperature of 2-8 ℃, and the pH = 6.5-7.5, so as to obtain the composition slurry.
10. The method for preparing the composition for improving the physiological functions of livestock and poultry according to claim 6, wherein the step 2) of forming comprises the step of freeze-drying the composition slurry prepared in the step 1) to prepare the composition freeze-dried powder for improving the physiological functions of livestock and poultry.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111096924.2A CN113730552B (en) | 2021-09-18 | 2021-09-18 | Composition for improving physiological functions of livestock and poultry and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111096924.2A CN113730552B (en) | 2021-09-18 | 2021-09-18 | Composition for improving physiological functions of livestock and poultry and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113730552A true CN113730552A (en) | 2021-12-03 |
CN113730552B CN113730552B (en) | 2024-01-23 |
Family
ID=78739809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111096924.2A Active CN113730552B (en) | 2021-09-18 | 2021-09-18 | Composition for improving physiological functions of livestock and poultry and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113730552B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114917251A (en) * | 2022-05-27 | 2022-08-19 | 福建农业职业技术学院 | Preparation method of pig placenta transfer factor |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0838160A1 (en) * | 1996-10-25 | 1998-04-29 | Ajinomoto Co., Ltd. | The use of poly-gamma-glutamic acid for preparing an agent for increasing the phosphorus assimilation |
EP1591018A1 (en) * | 2004-04-28 | 2005-11-02 | Cybelia | Feed for laying hens, method of feeding and eggs enriched with essential elements |
CN105999231A (en) * | 2016-06-06 | 2016-10-12 | 张英杰 | Polypeptide composition, composition for improving livestock and poultry immune function, and preparation method of composition for improving livestock and poultry immune function |
CN106804880A (en) * | 2017-01-13 | 2017-06-09 | 山东利坤生物科技有限公司 | A kind of livestock and poultry supplement calcium feed addictive and its manufacture method |
CN110559421A (en) * | 2019-10-09 | 2019-12-13 | 内蒙古元本生物医药科技有限公司 | Medical application of placenta transfer factor and preparation method thereof |
CN111388505A (en) * | 2020-04-02 | 2020-07-10 | 李小波 | Preparation method of animal placenta transfer factor |
CN112690379A (en) * | 2020-12-30 | 2021-04-23 | 仲恺农业工程学院 | Preparation of zinc gluconate and application thereof in growth performance, tissue mineralization, antioxidation and immune response of freshwater fish |
CN112998136A (en) * | 2021-04-06 | 2021-06-22 | 北京中科万联科技有限公司 | Vitamin composition for livestock and poultry as well as preparation method and application thereof |
-
2021
- 2021-09-18 CN CN202111096924.2A patent/CN113730552B/en active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0838160A1 (en) * | 1996-10-25 | 1998-04-29 | Ajinomoto Co., Ltd. | The use of poly-gamma-glutamic acid for preparing an agent for increasing the phosphorus assimilation |
EP1591018A1 (en) * | 2004-04-28 | 2005-11-02 | Cybelia | Feed for laying hens, method of feeding and eggs enriched with essential elements |
CN105999231A (en) * | 2016-06-06 | 2016-10-12 | 张英杰 | Polypeptide composition, composition for improving livestock and poultry immune function, and preparation method of composition for improving livestock and poultry immune function |
CN106804880A (en) * | 2017-01-13 | 2017-06-09 | 山东利坤生物科技有限公司 | A kind of livestock and poultry supplement calcium feed addictive and its manufacture method |
CN110559421A (en) * | 2019-10-09 | 2019-12-13 | 内蒙古元本生物医药科技有限公司 | Medical application of placenta transfer factor and preparation method thereof |
CN111388505A (en) * | 2020-04-02 | 2020-07-10 | 李小波 | Preparation method of animal placenta transfer factor |
CN112690379A (en) * | 2020-12-30 | 2021-04-23 | 仲恺农业工程学院 | Preparation of zinc gluconate and application thereof in growth performance, tissue mineralization, antioxidation and immune response of freshwater fish |
CN112998136A (en) * | 2021-04-06 | 2021-06-22 | 北京中科万联科技有限公司 | Vitamin composition for livestock and poultry as well as preparation method and application thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114917251A (en) * | 2022-05-27 | 2022-08-19 | 福建农业职业技术学院 | Preparation method of pig placenta transfer factor |
Also Published As
Publication number | Publication date |
---|---|
CN113730552B (en) | 2024-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105395676B (en) | A kind of compound medicament composition for treating animal mycotoxicosis | |
CN105639401A (en) | Feeding mold removal agent formula and application method | |
JPH0655107B2 (en) | Anti-pseudorabies and anti-pathogenic feed and feed additives for livestock, poultry and seafood | |
RU2694192C2 (en) | Additive containing baicalin, in particular from scutellaria baicalensis extract, and animal fodder containing such additive | |
CN105941870A (en) | Nanometer montmorillonite feed additive compound for detoxifying and diarrhea prevention of livestock and poultry | |
CN113730552B (en) | Composition for improving physiological functions of livestock and poultry and preparation method thereof | |
CN106721305A (en) | It is a kind of to improve compositions of additives of body condition or its production performance and preparation method thereof after Farrowing | |
CN101715893B (en) | Pure natural piglet immunological enhancement feed additive and application thereof | |
CN102696887A (en) | Feed active egg powder with nutrition, healthcare and growth promotion functions and production method thereof | |
Riad et al. | Effect of Spirulina platensis microalga additive on performance of growing Friesian calves | |
CN102304182B (en) | Preparation method and use of enterotoxigenic Escherichia coli egg yolk antibody powder | |
CN104208678B (en) | A kind of antivirus veterinary composition, lyophilized powder, preparation method and application | |
CN102754733A (en) | Novel micro-ecologic preparation for pig and preparation method thereof | |
CN108165522B (en) | Embryonic-period supplement for improving quality of broiler chickens and promoting early growth and application thereof | |
RU2259832C2 (en) | Preparation for stimulating metabolism and immunity in agricultural animals and birds | |
JP2001224317A (en) | Feed composition | |
RU2285399C1 (en) | Method for increasing meat productivity of youngsters in fattening swine | |
CN113508876A (en) | Selenium-rich and zinc-rich feed and preparation method thereof | |
CN106666150A (en) | Nonreactive health-care agent capable of improving production performance of breeding pigs and preparation method of nonreactive health-care agent | |
CN105661039A (en) | Breeding sow feed additives and preparation method thereof | |
RU2524664C1 (en) | Method of prevention of mass gastrointestinal and respiratory diseases of suckling pigs | |
RU2723179C1 (en) | Method for improving economic and useful qualities of ewes and lambs | |
CN113244220A (en) | Application of potassium dehydroandrographolide succinate in preparation of veterinary drug for treating cow mastitis and potassium dehydroandrographolide succinate veterinary drug | |
RU2471359C1 (en) | Method for correction of immunobiological indices with piglets in period of weaning | |
Aziz et al. | The effect of modern care methods on the mortality rate of Dromedary camels calves |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |